• Improves Postprandial Glucose Control

    In human studies, allulose consumed with carbohydrate-containing meals has been shown to reduce the post-meal blood sugar spike [1,4].

  • May Stimulate GLP-1 and Improve Insulin Sensitivity

    In some studies, allulose has been shown to stimulate GLP-1 secretion, an incretin hormone involved in glucose metabolism and appetite signaling [5].

  • May Reduce Abdominal Fat and Improve Metabolic Markers

    A 12-week study in overweight adults found that daily consumption of 7-10g of allulose was associated with modest reductions in body fat and improvements in certain metabolic markers [2]. RARE Gum provides 2g per serving.

  • Gentle On Your Gut

    A human study showed that allulose is well tolerated in doses up to 0.4 g per kg of body weight (about 27g for a 150lb person) with no reported bloating, cramping, or diarrhea [3].

Small Ingredient. Big Impact.

Allulose isn’t just a sweetener—it’s a wellness tool.

Shop Functional Gum

The Research

  1. Braunstein, C. R., Noronha, J. C., Glenn, A. J., Viguiliouk, E., Noseworthy, R., Khan, T. A., Au‑Yeung, F., Blanco Mejia, S., Wolever, T. M. S., Josse, R. G., & Jenkins, D. J. A. (2018). A double‑blind, randomized controlled, acute feeding equivalence trial of small, catalytic doses of fructose and allulose on postprandial blood glucose metabolism in healthy participants: The FACE Trial. Nutrients, 10(6), 750. https://doi.org/10.3390/nu10060750
  2. Han, Y.-J., Ochiai, R., Yada, T., & Matsuo, T. (2016). Safety evaluation of 12-week continuous ingestion of D‑allulose in borderline diabetes and type 2 diabetes: Long‑term D‑allulose intake reduces body weight and fat mass. Journal of Clinical Biochemistry and Nutrition, 59(3), 184–189.
  3. Han Y, Choi BR, Kim SY, Kim S-B, Kim YH, Kwon E-Y, Choi M-S. Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults. A Non-Randomized Controlled Trial. Nutrients. 2018; 10(12):2010.
  4. Hayashi, N., Iida, T., Yamada, T., Okuma, K., Takehara, I., Yamamoto, T., Yamada, K., & Tokuda, M. (2010). Study on the postprandial blood glucose suppression effect of D‑psicose in borderline diabetes and the safety of long‑term ingestion by normal human subjects. Bioscience, Biotechnology, and Biochemistry, 74(3), 510–519. https://doi.org/10.1271/bbb.90707
  5. Tani, Y., Tokuda, M., Nishimoto, N., Yokoi, H., & Izumori, K. (2023). Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis. PLOS ONE, 18(4), e0281150. https://doi.org/10.1371/journal.pone.0281150 
  6. Teysseire, F., Bordier, V., Budzinska, A., Weltens, N., Rehfeld, J. F., Holst, J. J., Hartmann, B., Beglinger, C., Van Oudenhove, L., Wölnerhanssen, B. K., & Meyer‑Gerspach, A. C. (2022). The role of D‑allulose and erythritol on the activity of the gut sweet taste receptor and gastrointestinal satiation hormone release in humans: A randomized, controlled trial. The Journal of Nutrition, 152(5), 1228–1238.